ArticleOncology letters2019

Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B-cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3.

Ting Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.